Literature DB >> 19656700

Transforming growth factor-beta1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants.

Carlos Gonzalez1, Kiem G Auw Yang, Joseph H Schwab, James S Fitzsimmons, Monica M Reinholz, Zachary T Resch, Laurie K Bale, Victoria R Clemens, Cheryl A Conover, Shawn W O'Driscoll, Gregory G Reinholz.   

Abstract

OBJECTIVE: Periosteum is involved in bone growth and fracture healing and has been used as a cell source and tissue graft for tissue engineering and orthopedic reconstruction including joint resurfacing. Periosteum can be induced by transforming growth factor beta (TGF-beta) or insulin-like growth factor-I (IGF-I) alone or in combination to form cartilage. However, little is known about the interaction between IGF and TGF-beta signaling during periosteal chondrogenesis. The purpose of this study was to determine the effect of TGF-beta1 on IGF binding protein-4 (IGFBP-4) and the IGFBP-4 protease pregnancy-associated plasma protein-A (PAPP-A) expression in cultured periosteal explants.
DESIGN: Periosteal explants from rabbits were cultured with or without TGF-beta1. IGFBP-4 and PAPP-A mRNA levels were determined by real-time quantitative PCR. Conditioned medium was analyzed for IGFBP-4 and PAPP-A protein levels and IGFBP-4 protease activity.
RESULTS: TGF-beta1-treated explants contained lower IGFBP-4 mRNA levels throughout the culture period with a maximum reduction of 70% on day 5 of culture. Lower levels of IGFBP-4 protein were also detected in the conditioned medium from TGF-beta1-treated explants. PAPP-A mRNA levels were increased 1.6-fold, PAPP-A protein levels were increased threefold, and IGFBP-4 protease activity was increased 8.5-fold between 7 and 10days of culture (the onset of cartilage formation in this model) in conditioned medium from TGF-beta1-treated explants.
CONCLUSIONS: This study demonstrates that TGF-beta1 modulates the expression of IGFBP-4 and PAPP-A in cultured periosteal explants. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656700      PMCID: PMC2844918          DOI: 10.1016/j.ghir.2009.06.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  47 in total

1.  In vivo engineering of organs: the bone bioreactor.

Authors:  Molly M Stevens; Robert P Marini; Dirk Schaefer; Joshua Aronson; Robert Langer; V Prasad Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

2.  Gene digging. A method for obtaining species-specific sequence based on conserved segments of nucleotides in open reading frames.

Authors:  A Sanyal; S W O'Driscoll; J S Fitzsimmons; M E Bolander; G Sarkar
Journal:  Mol Biotechnol       Date:  1998-12       Impact factor: 2.695

3.  Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.

Authors:  X Qin; D Byun; D D Strong; D J Baylink; S Mohan
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

4.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

Authors:  S Mohan; C M Bautista; J Wergedal; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Expression and release of insulin-like growth factor binding proteins in isolated epiphyseal growth plate chondrocytes from the ovine fetus.

Authors:  P De Los Rios; D J Hill
Journal:  J Cell Physiol       Date:  2000-05       Impact factor: 6.384

6.  Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3',5'-monophosphate-dependent mechanism.

Authors:  O Tørring; A F Firek; H Heath; C A Conover
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

7.  Enhancement of periosteal chondrogenesis in vitro. Dose-response for transforming growth factor-beta 1 (TGF-beta 1).

Authors:  Y Miura; J S Fitzsimmons; C N Commisso; S H Gallay; S W O'Driscoll
Journal:  Clin Orthop Relat Res       Date:  1994-04       Impact factor: 4.176

8.  Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.

Authors:  Christopher O Ortiz; Bing-Kun Chen; Laurie K Bale; Michael T Overgaard; Claus Oxvig; Cheryl A Conover
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

9.  Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.

Authors:  S K Durham; M C Kiefer; B L Riggs; C A Conover
Journal:  J Bone Miner Res       Date:  1994-01       Impact factor: 6.741

10.  Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants.

Authors:  C A Conover; S K Durham; J Zapf; F R Masiarz; M C Kiefer
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

View more
  3 in total

1.  TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.

Authors:  Samantha Gardner; Damir Alzhanov; Paul Knollman; David Kuninger; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-11-24

2.  Tissue-specific changes in pregnancy associated plasma protein-A expression with age in mice.

Authors:  Sara L Harstad; Cheryl A Conover
Journal:  Exp Gerontol       Date:  2014-05-09       Impact factor: 4.032

3.  Investigation of the binding network of IGF-I on the cavity surface of IGFBP4.

Authors:  Xin Chen; Shuyan Zhu; Danhui Duan; Tao Wu; Qi Wang
Journal:  J Mol Model       Date:  2013-10-17       Impact factor: 1.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.